Aurinia Pharmaceuticals
AUPH
AUPH
200 hedge funds and large institutions have $525M invested in Aurinia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 64 increasing their positions, 50 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.09% less ownership
Funds ownership: 40.95% → 40.86% (-0.09%)
21% less call options, than puts
Call options by funds: $13.3M | Put options by funds: $16.8M
Holders
200
Holding in Top 10
1
Calls
$13.3M
Puts
$16.8M
Top Buyers
| 1 | +$9.79M | |
| 2 | +$8.78M | |
| 3 | +$6.93M | |
| 4 |
Lazard Asset Management
New York
|
+$3.76M |
| 5 |
JP Morgan Chase
New York
|
+$3.46M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$8.65M | |
| 3 | -$5.35M | |
| 4 |
SG Americas Securities
New York
|
-$3.96M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.09M |